Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes

Table 2

Intraoperative and postoperative results with high intensity focused ultrasound.

Anesthesia used
Spinal anesthesia	109
General anesthesia	1
Ablatherm device
EDAP-Technomed Ablatherm	59
Ablatherm Integrated Imaging	51
Preoperative complications	0
Concomitant TURP, 𝑛 (%)
Yes	79 (71.8)
No	31 (28.2)
Hospital stays in days, median (range)	4 (2–7)
Catheterization time in days, median (range)	6 (2–30)
Postoperative prostatic volume in mL, median (range)	14 (6–22)
Time to PSA nadir in weeks, mean (range)	16.3 ± 8.2 (4–46)
PSA nadir in ng/mL, mean (range)	0.55 ± 1.34 (0–8.29)
PSA < 0.5 ng/mL, 𝑛 (%)	72 (65.5)
PSA 0.5–1 ng/mL, 𝑛 (%)	17 (15.5)
PSA 1–4 ng/mL, 𝑛 (%)	19 (17.2)
PSA > 4 ng/mL, 𝑛 (%)	2 (1.8)
Follow-up in months, median (range)	94 (13–139)
Lost to follow-up, 𝑛 (%)	2 (1.8)